Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...
TUESDAY commemorates World Cancer Awareness Day. This year’s theme is United by Unique which is a patient-centric initiative to improve understanding that underlying every cancer diagnosis is a unique ...
17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin ... B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy ...
Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...